EMD-35156

Single-particle
3.6 Å
EMD-35156 Deposition: 18/01/2023
Map released: 04/10/2023
Last modified: 16/10/2024
Overview 3D View Sample Experiment Validation Additional data Links
Overview 3D View Sample Experiment Validation Additional data Links

EMD-35156

Archive Files (Depositor)

Primary 3D volume (map.gz) Half-map 1 Half-map 2 (map.gz) Experimental metadata (xml) Experimental metadata (cif.gz)

Validation (wwPDB)

Map-only validation report (pdf.gz) Map-8i3u summary report (pdf.gz) Map-8i3u FULL report (pdf.gz)

EMDB Annotations

EMICSS entry mapping (xml)

EMDB Files

VA raw map (map) VA resolution mask (mrc)

Local CryoEM structure of the SARS-CoV-2 S6P in complex with 14B1 Fab

EMD-35156

Single-particle
3.6 Å
EMD-35156 Deposition: 18/01/2023
Map released: 04/10/2023
Last modified: 16/10/2024
Overview 3D View Sample Experiment Validation Additional data Links
Sample Organism: Severe acute respiratory syndrome coronavirus 2, Homo sapiens
Sample: Spike-Fab complex
Fitted models: 8i3u

Deposition Authors: Li Z, Yu F, Cao S
Broadly neutralizing antibodies derived from the earliest COVID-19 convalescents protect mice from SARS-CoV-2 variants challenge.
Liu Q, Zhao H, Li Z, Zhang Z, Huang R, Gu M, Zhuang K, Xiong Q, Chen X, Yu W, Qian S, Zhang Y, Tan X, Zhang M, Yu F, Guo M, Huang Z, Wang X, Xiang W, Wu B, Mei F, Cai K , Zhou L, Zhou L, Wu Y, Yan H , Cao S , Lan K , Chen Y
(2023) Signal Transduct Target Ther , 8 , 347 - 347
PUBMED: 37704615
DOI: doi:10.1038/s41392-023-01615-0
ISSN: 2059-3635